These data correlate with what has already been described in the literature where TTF-1 has been shown to be a better prognostic factor in adenocarcinomas of all stages and where TTF-1 positivity increases the probability of finding EGFR or ALK mutations [17,18,19,20,21,22,23]. This evidence concerns the gene EGFR and adenocarcinoma.